Drugs / FMT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05094765 | Nov 2021 → Mar 2023 | acute graft versus host disease | Shenzhen Xbiome Biotech Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05094765 ↗ |